Abstract
We studied the acceptability of isoniazid preventive therapy (IPT) in newly human immunodeficiency virus (HIV) infected Ugandan women. Women were followed in an out-patient clinic where they received HIV care including IPT. Of 52 women who were purified protein derivative-positive, 48 were eligible for IPT and 39 (81%) completed therapy. This completion rate was higher than reported in similar observational studies.
Publication types
-
Multicenter Study
-
Research Support, N.I.H., Extramural
MeSH terms
-
Adolescent
-
Adult
-
Antitubercular Agents / therapeutic use*
-
Cohort Studies
-
Female
-
HIV Infections / complications*
-
Humans
-
Isoniazid / therapeutic use*
-
Latent Tuberculosis / complications
-
Latent Tuberculosis / diagnosis
-
Latent Tuberculosis / drug therapy*
-
Prospective Studies
-
Treatment Outcome
-
Tuberculin Test
-
Tuberculosis / prevention & control
-
Uganda
-
Young Adult
Substances
-
Antitubercular Agents
-
Isoniazid